Patent · US Active

D-serine inhibit neuroinflammation due to a brain injury

US11484519B2 · kind B2 · utility

1Cited by

5References

26Claims

0Family size

Assignee

Florida State University Research Foundation, Inc. · US

Inventors

Sanjay Kumar · Moraga, US
Stephen Beesley · Tallahassee, US

Key dates

Filing date	Mar 9, 2020
Grant date	Nov 1, 2022
Priority date	—
Expiry date	Sep 8, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

D-serine is effective for inhibiting neuron loss due to an immune response by glial cells to a brain injury. An example of a method includes artificially administering a composition including D-serine to brain cells after an injury thereto, the composition including an amount of D-serine effective to inhibit death of neurons.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.